MPM Asset Management LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
MPM Asset Management LLC disclosed 6 US equity positions worth $124.4m in its Q4 2024 13F filing. The largest position was TRDA at 60.9% of the reported book, followed by 2662247D and DYN. Against the Q3 2024 filing, it opened 0 new positions, added to 0 and reduced 2 among the top 6 holdings.
What did MPM Asset Management LLC own in Q4 2024? Top 6 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TRDA Entrada Therapeutics, Inc. | 60.9% | $75.7m | 4,381,062 | -1% | reduced | |
| 2 | 2662247D iTeos Therapeutics, Inc. | 16.9% | $21.0m | 2,738,785 | 0% | held | |
| 3 | DYN Dyne Therapeutics, Inc. | Healthcare | 12.9% | $16.1m | 682,376 | 0% | held |
| 4 | HOWL Werewolf Therapeutics, Inc. | 5.1% | $6.3m | 4,284,172 | 0% | held | |
| 5 | ADAPY Adaptimmune Therapeutics plc | Healthcare | 2.4% | $3.0m | 5,555,461 | 0% | held |
| 6 | RPTX Repare Therapeutics, Inc. | 1.8% | $2.2m | 1,683,707 | -25% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.